To further analyse these chromatin structure alterations, we chose two genes as markers of response to anti‐IgM in U‐CLL (EGR1 and DUSP2) and investigated the changes in mRNA level and chromatin structure in response to BCR cross‐linking. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.